EGFR and non-small cell lung carcinoma: The epidermal growth factor receptor (EGFR) is considered a molecular target for the treatment of cancer due to its abnormal expression or activation in a variety of cancer cells, especially non-small-cell lung cancer (NSCLC), which accounts for 84% of lung tumors [1,2].